↓ Skip to main content

Dove Medical Press

FOLFIRI and regorafenib combination therapy with dose escalation of irinotecan as fourth-line treatment for patients with metastatic colon cancer according to UGT1A1 genotyping

Overview of attention for article published in OncoTargets and therapy, November 2014
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • Good Attention Score compared to outputs of the same age (76th percentile)
  • High Attention Score compared to outputs of the same age and source (91st percentile)

Mentioned by

patent
3 patents

Citations

dimensions_citation
14 Dimensions

Readers on

mendeley
25 Mendeley
Title
FOLFIRI and regorafenib combination therapy with dose escalation of irinotecan as fourth-line treatment for patients with metastatic colon cancer according to UGT1A1 genotyping
Published in
OncoTargets and therapy, November 2014
DOI 10.2147/ott.s69774
Pubmed ID
Authors

Chien-Yu Lu, Yung-Sung Yeh, Ching-Wen Huang, Cheng-Jen Ma, Fang-Jung Yu, Jaw-Yuan Wang

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 25 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Portugal 1 4%
Unknown 24 96%

Demographic breakdown

Readers by professional status Count As %
Other 6 24%
Researcher 5 20%
Student > Postgraduate 3 12%
Student > Ph. D. Student 2 8%
Student > Master 2 8%
Other 4 16%
Unknown 3 12%
Readers by discipline Count As %
Medicine and Dentistry 14 56%
Agricultural and Biological Sciences 3 12%
Chemistry 2 8%
Biochemistry, Genetics and Molecular Biology 1 4%
Unknown 5 20%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 6. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 20 February 2024.
All research outputs
#5,447,195
of 25,374,917 outputs
Outputs from OncoTargets and therapy
#278
of 3,016 outputs
Outputs of similar age
#59,413
of 273,831 outputs
Outputs of similar age from OncoTargets and therapy
#2
of 23 outputs
Altmetric has tracked 25,374,917 research outputs across all sources so far. Compared to these this one has done well and is in the 75th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 3,016 research outputs from this source. They receive a mean Attention Score of 2.9. This one has done well, scoring higher than 89% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 273,831 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 76% of its contemporaries.
We're also able to compare this research output to 23 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 91% of its contemporaries.